Retour
NovaBay Pharmaceuticals Inc (NBY) Gagner
Graphique du cours de l'action NBY
NBY Gagner
NovaBay Pharmaceuticals Inc
$1.57
13.77%
$0.19
À partir d'aujourd'hui :Mar 24, 16:12:16 GMT-4
Statistiques clés
Clôture préc.
$1.37
Prix d'ouverture
$1.31
Plage de la journée
$1.29 - $1.75
Plage de 52 semaines
$1.11 - $99.75
Volume
1.1M
Volume moyen
509.9K
Rendement en dividend
--
BPA (TTM)
-6.62
Capitalisation boursière
$41.0M
Qu’est-ce que NBY ?
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.